Furthermore, we found that KAT6A knockout, but not catalytic inhibition of KAT6A using a small‐molecule inhibitor (WM1119),[6, 7] restored the PARPi sensitivity of ovarian cancer cells (Figure 1I–K; Figure S1D, Supporting Information). Here, KAT6A is linked to ovarian cancer.